人类免疫缺陷病毒疫苗的现状

Vaccination research : open journal Pub Date : 2016-12-31 DOI:10.17140/vroj-1-e002

D. Sosa, R. Jayant, A. Kaushik, M. Nair

{"title":"人类免疫缺陷病毒疫苗的现状","authors":"D. Sosa, R. Jayant, A. Kaushik, M. Nair","doi":"10.17140/vroj-1-e002","DOIUrl":null,"url":null,"abstract":"Highly Active Antiretroviral Therapies (HAARTs) have been developed to treat HIV+ individuals, increasing the quality and quantity of life of many HIV+ patients. Despite these effective strategies, human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) epidemic continues to uphold globally with 39 million infected individuals.","PeriodicalId":93237,"journal":{"name":"Vaccination research : open journal","volume":"31 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2016-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Current Status of Human Immunodeficiency Virus Vaccines\",\"authors\":\"D. Sosa, R. Jayant, A. Kaushik, M. Nair\",\"doi\":\"10.17140/vroj-1-e002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Highly Active Antiretroviral Therapies (HAARTs) have been developed to treat HIV+ individuals, increasing the quality and quantity of life of many HIV+ patients. Despite these effective strategies, human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) epidemic continues to uphold globally with 39 million infected individuals.\",\"PeriodicalId\":93237,\"journal\":{\"name\":\"Vaccination research : open journal\",\"volume\":\"31 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccination research : open journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17140/vroj-1-e002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccination research : open journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17140/vroj-1-e002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 2

摘要

高效抗逆转录病毒疗法(HAARTs)已被开发用于治疗艾滋病毒阳性个体，提高了许多艾滋病毒阳性患者的生活质量和数量。尽管有这些有效的战略，人体免疫机能丧失病毒感染和获得性免疫机能丧失综合症(艾滋病毒/艾滋病)在全球继续流行，感染人数达3 900万人。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Current Status of Human Immunodeficiency Virus Vaccines

Highly Active Antiretroviral Therapies (HAARTs) have been developed to treat HIV+ individuals, increasing the quality and quantity of life of many HIV+ patients. Despite these effective strategies, human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) epidemic continues to uphold globally with 39 million infected individuals.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Vaccination research : open journal

自引率

0.00%

发文量